The Manufacturers Life Insurance Company lifted its stake in shares of Humana Inc. (NYSE:HUM – Free Report) by 10.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 70,185 shares of the insurance provider’s stock after purchasing an additional 6,690 shares during the period. The Manufacturers Life Insurance Company owned about 0.06% of Humana worth $27,879,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also recently modified their holdings of the company. Johnson Financial Group Inc. acquired a new stake in Humana in the 2nd quarter worth about $26,000. Trust Co. of Vermont acquired a new position in shares of Humana during the second quarter valued at approximately $28,000. Bogart Wealth LLC lifted its position in shares of Humana by 192.0% in the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after acquiring an additional 48 shares in the last quarter. MidFirst Bank purchased a new position in shares of Humana in the second quarter valued at approximately $35,000. Finally, Fideuram Asset Management Ireland dac acquired a new stake in shares of Humana in the fourth quarter worth approximately $27,000. Institutional investors and hedge funds own 92.38% of the company’s stock.
Analyst Ratings Changes
Several analysts recently commented on the company. Mizuho boosted their price target on Humana from $335.00 to $390.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. TD Cowen lifted their target price on shares of Humana from $350.00 to $370.00 and gave the stock a “hold” rating in a research note on Friday, July 31st. Wolfe Research reaffirmed an “outperform” rating and set a $450.00 target price on shares of Humana in a research note on Monday, August 24th. Robert W. Baird set a $390.00 target price on shares of Humana in a research report on Thursday, July 30th. Finally, William Blair assumed coverage on shares of Humana in a research note on Wednesday, May 20th. They issued an “outperform” rating on the stock. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $403.91.
Humana Stock Performance
NYSE HUM opened at $408.79 on Friday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The stock’s fifty day moving average is $388.94 and its two-hundred day moving average is $303.54. The firm has a market capitalization of $49.09 billion, a P/E ratio of 38.67, a price-to-earnings-growth ratio of 2.53 and a beta of 0.74. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $428.88.
Humana (NYSE:HUM – Get Free Report) last issued its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. The business had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company’s revenue for the quarter was up 26.2% on a year-over-year basis. During the same period last year, the company earned $6.27 EPS. On average, research analysts anticipate that Humana Inc. will post 9 earnings per share for the current year.
Humana Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Friday, October 30th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, October 30th. Humana’s payout ratio is presently 33.49%.
Humana Company Profile
Humana Inc (NYSE:HUM) is a U.S.-based health insurance and health care services company focused primarily on government-sponsored programs. Its offerings include Medicare Advantage plans, Medicare prescription drug plans, Medicaid coverage and specialty insurance products, serving individuals, employers and government organizations.
Through its CenterWell business, Humana also provides senior-focused primary care, pharmacy services and home health care. These operations are designed to support coordinated care for older adults and other members with ongoing health care needs.
Humana was founded in 1961 as a nursing-home company and later expanded into hospital ownership before shifting its focus toward health insurance.
Recommended Stories
- Five stocks we like better than Humana
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
